We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical industry officials Thursday urged European Union member states to reconsider recently introduced drug pricing systems to contain the increase in healthcare spending, saying they stifle innovation and growth in the region.
recently published study shows multiple sclerosis (MS) drug Copaxone, marketed by Israeli drugmaker Teva Pharmaceutical and sanofi-aventis, reduced annual relapse rates 75 percent in patients who switched to Copaxone from MS treatment Betaseron, the drugmakers announced.
The Switzerland-based Debiopharm Group, a biopharmaceutical development company specializing in oncology and serious medical conditions, and Aurigene Discovery Technologies, based in India, have signed a research agreement to identify and develop compounds for two innovative immuno-oncology targets.
Japan-based Bayer Yakuhin has submitted a marketing application of an orally available anticancer drug, Nexavar (sorafenib) for the treatment of advanced renal cell carcinoma (RCC), which was developed by Bayer HealthCare AG and Onyx Pharmaceuticals, to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.
Banyu Pharmaceutical recently published the results of the Japan Lipid Intervention Trial (J-LIT), large-scale clinical trials of LIPOVAS, its proprietary anti-hyperlipidemic agent, in Circulation Journal (Vol.70, No.7), an academic and professional publication of the Japanese Circulation Society.
Usually high-flying Medicis Pharmaceutical Corp. gave up nearly a third of its share value during the last few weeks.Shares of the Scottsdale-based company, which hovered near $35 in mid-May, slipped 23 cents to $23.77 Tuesday, straddling a new three-year low.
Takeda Pharmaceutical Co. on Wednesday denied it failed to declare 122.3 billion yen (US$1.05 billion; euro0.84 billion) in taxable income over six years to March 2005, rebuffing claims by tax authorities and saying it will fight an order to pay back taxes.